Publications by authors named "Claire Caprio"
Hematopoietic stem cells (HSCs) sustain life-long hematopoiesis and emerge during mid-gestation from hemogenic endothelial progenitors via an endothelial-to-hematopoietic transition (EHT). The full scope of molecular mechanisms governing this process remains unclear. The NR4A subfamily of orphan nuclear receptors act as tumor suppressors in myeloid leukemogenesis and have never been implicated in HSC specification.
View Article and Find Full Text PDFArticle Synopsis
- The text discusses the importance of certain proteins in regulating CXCR4, which is crucial for B-cell movement and function in the germinal center.
- It highlights that the absence of specific genes can lead to abnormal B-cell development, increased mutation rates, and a high risk of developing aggressive B-cell cancers in mice.
- Additionally, the study suggests that these gene deficiencies create a model that mimics human aggressive B-cell lymphomas, offering insights into the mechanisms behind these blood cancers.
Hematopoietic stem cells (HSCs) can generate all blood cells. This ability is exploited in HSC transplantation (HSCT) to treat hematologic disease. A clear understanding of the molecular mechanisms that regulate HSCT is necessary to continue improving transplant protocols.
View Article and Find Full Text PDFCurrent dogma asserts that the foetal liver (FL) is an expansion niche for recently specified haematopoietic stem cells (HSCs) during ontogeny. Indeed, between embryonic day of development (E)12.5 and E14.
View Article and Find Full Text PDFWhile adult bone marrow (BM) hematopoietic stem and progenitor cells (HSPCs) and their extrinsic regulation is well studied, little is known about the composition, function, and extrinsic regulation of the first HSPCs to enter the BM during development. Here, we functionally interrogate murine BM HSPCs from E15.5 through P0.
View Article and Find Full Text PDFHematopoietic stem cell (HSC) transplantation (HSCT) is often exploited to treat hematologic disease. Donor HSCs must survive, proliferate, and differentiate in the damaged environment of the reconstituting niche. Illuminating molecular mechanisms regulating the activity of transplanted HSCs will inform efforts to improve HSCT.
View Article and Find Full Text PDF